Pluri (FRA:4DX) LT-Debt-to-Total-Asset: 0.22 (As of Mar. 2026)

Pluri FRA:4DX 29 LT-Debt-to-Total-Asset is 0.22 as of Mar. 2026. GuruFocus rates FRA:4DX with a GF Score™ of 29/100 and a GF Value™ of €17.39. The stock has 6 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Pluri's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.22.

Pluri's long-term debt to total assets ratio declined from Mar. 2025 (0.82) to Mar. 2026 (0.22). It may suggest that Pluri is progressively becoming less dependent on debt to grow their business.

Pluri (FRA:4DX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Pluri LT-Debt-to-Total-Asset Related Terms

Pluri LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Pluri's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pluri LT-Debt-to-Total-Asset Chart

Pluri Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.26

0.41

0.58

0.74

0.16

Pluri Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.82	0.16	0.18	0.20	0.22

29GF Score

Pluri Inc FRA:4DX

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Pluri LT-Debt-to-Total-Asset Calculation

Pluri's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

LT Debt to Total Assets (A: Jun. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2025 )	/	Total Assets (A: Jun. 2025 )
	=	5.29	/	33.538
	=	0.16

Pluri's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	4.844	/	22.539
	=	0.21

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.22 mean?

Pluri (FRA:4DX) has a LT-Debt-to-Total-Asset of 0.22 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Pluri and its competitors.

Is Pluri's LT-Debt-to-Total-Asset too high?

Pluri's current LT-Debt-to-Total-Asset is 0.22. Overall, Pluri has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.

How does Pluri's LT-Debt-to-Total-Asset compare to MRKR and VYNE?

Pluri's LT-Debt-to-Total-Asset of 0.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Biotechnology company?

A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Pluri and its competitors. Pluri's current LT-Debt-to-Total-Asset is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pluri stock overvalued right now?

Pluri (FRA:4DX) has a current LT-Debt-to-Total-Asset of 0.22. The stock's GF Value™ is €17.39, compared to a current price of €5.60 — trading 67.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.22. Pluri's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Pluri (FRA:4DX), the current LT-Debt-to-Total-Asset is 0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pluri (FRA:4DX) Overvalued in 2026?

Based on GuruFocus' analysis, Pluri stock appears to be undervalued. The current stock price of €5.60 is trading 67.8% below its estimated GF Value™ of €17.39.

Key valuation signals for FRA:4DX:

LT-Debt-to-Total-Asset: 0.22
GF Value™: €17.39 vs. price of €5.60 (67.8% below fair value)
GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the FRA:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pluri Business Description

Industry Healthcare Biotechnology

Comparable Companies MRKR VYNE LGVN ALLR NCEL LPCN PTN CLRB SKYE PLRZ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges PLUR:USA PLUR:Israel

Address MATAM Advanced Technology Park, Building No. 5, Haifa, ISR, 3508409

Website https://www.pluri-biotech.com

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

29GF Score

Get the complete analysis for FRA:4DX

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.60

Price

€17.39

GF Value

View FRA:4DX Analysis

See LT-Debt-to-Total-Asset data for all stocks →